Knowledge Center
Patent / Aug 04, 2022
Inhaled ivermectin
Source:
US 20220241307
The present invention contemplates the use of inhaled ivermectin for use in various viruses and parasitic infections (treatment and/or prophylaxis) that are present or manifest in the lungs or respiratory tract. Exemplary dosing, formulations, devices, and processing techniques are also disclosed herein.
Ìý
Also in the Knowledge Center
/ Jan 01, 2013
Application of high dose compounds via inhalation for treatment of pulmonary diseases
Read more
Scientific Article
/ Jan 01, 2012
Preparation of electrophilic sulfur reagents for monohalomethylation of steroids
Read more
Scientific Article
/ Jan 01, 2012
Manufacture of a triiodinated contrast agent via a new compound of (S)-5-(2-acetoxypropanamido)-2,4,6-triiodoisophthalic acid
Read more
Scientific Article